Lowe Brockenbrough & CO Inc Novo Nordisk A S Transaction History

Lowe Brockenbrough & CO Inc

$1.55 Billion
Q3 2024

A detailed history of Lowe Brockenbrough & CO Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Lowe Brockenbrough & CO Inc holds 32,782 shares of NVO stock, worth $3.34 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

32,782

Previous 33,250 1.41%

Holding current value

$3.34 Million

Previous $4.75 Million 17.76%

% of portfolio

0.25%

Previous 0.32%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$119.07 - $145.42 $55,724 - $68,056	-468 Reduced 1.41%	32,782 $3.9 Million
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $138,662 - $166,008	-1,130 Reduced 3.29%	33,250 $4.75 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $328,385 - $437,118	-3,216 Reduced 8.55%	34,380 $4.41 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $135,444 - $162,709	1,543 Added 4.28%	37,596 $3.89 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.57 Million - $3.44 Million	17,247 Added 91.71%	36,053 $3.28 Million
Q2 2023 Aug 10, 2023	SELL	$155.98 - $172.65 $15,442 - $17,092	-99 Reduced 0.52%	18,806 $3.04 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $23,821 - $28,645	-180 Reduced 0.94%	18,905 $3.01 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $39,584 - $52,237	-386 Reduced 1.98%	19,085 $2.58 Million
Q3 2022 Nov 01, 2022	SELL	$95.28 - $116.93 $22,009 - $27,010	-231 Reduced 1.17%	19,471 $1.94 Million
Q2 2022 Jul 27, 2022	SELL	$103.24 - $121.81 $194,607 - $229,611	-1,885 Reduced 8.73%	19,702 $2.2 Million
Q1 2022 May 04, 2022	SELL	$93.1 - $112.54 $56,791 - $68,649	-610 Reduced 2.75%	21,587 $2.42 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $47,940 - $58,540	-500 Reduced 2.2%	22,197 $2.49 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $5,909 - $7,463	70 Added 0.31%	22,697 $2.18 Million
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $6,021 - $7,543	89 Added 0.39%	22,627 $1.9 Million
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $10,059 - $11,372	-150 Reduced 0.66%	22,538 $1.52 Million
Q4 2020 Feb 04, 2021	SELL	$63.89 - $73.8 $45,042 - $52,029	-705 Reduced 3.01%	22,688 $1.59 Million
Q3 2020 Oct 26, 2020	SELL	$63.69 - $70.22 $12,738 - $14,044	-200 Reduced 0.85%	23,393 $1.62 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $43,905 - $50,955	-750 Reduced 3.08%	23,593 $1.55 Million
Q1 2020 May 21, 2020	SELL	$49.46 - $64.78 $16,074 - $21,053	-325 Reduced 1.32%	24,343 $1.47 Million
Q3 2019 Nov 21, 2019	BUY	$47.54 - $53.43 $41,597 - $46,751	875 Added 3.68%	24,668 $1.28 Million
Q2 2019 Aug 12, 2019	BUY	$46.79 - $52.47 $2,105 - $2,361	45 Added 0.19%	23,793 $1.21 Million
Q1 2019 May 21, 2019	SELL	$46.36 - $52.63 $6,954 - $7,894	-150 Reduced 0.63%	23,748 $1.24 Million
Q4 2018 Feb 15, 2019	BUY	$41.54 - $47.25 $992,722 - $1.13 Million	23,898 New	23,898 $1.1 Million

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Brockenbrough & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Brockenbrough & CO Inc with notifications on news.

Account

Lowe Brockenbrough & CO Inc Novo Nordisk A S Transaction History